Jakarta, InfoPublik – The Pfizer vaccine with the COMIRNATY brand that has arrived in Indonesia will first be intended for the general public who have never received a free COVID-19 vaccine before.
In the early stages, this vaccine has been distributed to the Greater Jakarta area. The priority of giving to the Greater Jakarta area is due to the complex logistics system compared to other types of vaccines.
“This vaccine must be prepared by health workers who have been trained to use certain techniques in dealing with the cold chain, including how to dilute and dilute the vaccine before it is injected,” said Head of the Communication and Public Service Bureau of the Ministry of Health, Widyawati in an official statement on Saturday (21/8/2021). .
Pfizer vaccines require special handling and storage and must be used immediately, because the specifications of this vaccine must be stored specifically in a place with a very low temperature between -90 to -60 degrees Celsius.
Widya said the government continues to bring in the best vaccines from various manufacturers in order to secure the availability of vaccines to protect the 208 million Indonesians who are the targets of the COVID-19 vaccination.
Although there are several types of vaccines in Indonesia, Widya urges the public not to be picky about vaccines because the government has guaranteed the safety and efficacy of the COVID-19 vaccine currently used.
A total of 1,560,780 million doses of Pfizer vaccine arrived in Indonesia on Thursday (19/8/2021) through a direct purchase scheme. Gradually, 50 million Pfizer vaccines will arrive in Indonesia this year through the scheme.
This amount does not include the Pfizer vaccine which will be obtained free of charge through the GAVI/Covax scheme of 4.6 million doses in the next few weeks.
Vaccines Pfizer has acquired Emergency Use Authorization (EUA) from the Food and Drug Supervisory Agency (BPOM) on July 14, 2021, so that it can be directly injected into the community. Currently, there are six types of vaccines used in Indonesia to fight the COVID-19 virus.
These are the Coronavac vaccine, the finished vaccine made by Sinovac from China, the COVID-19 vaccine, the vaccine produced by Bio Farma with raw materials from Sinovac, the AstraZeneca vaccine from the UK, the Moderna vaccine and Pfizer from the United States.
(Photo: Ministry of Health)